AMAG Pharmaceuticals, Inc.
24 clinical trials · Sponsor
◉ Watch AMAG Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults (NCT04593784) | AMAG Pharmaceuticals, Inc. | 2021-10-13 |
| A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects (NCT03893045) | AMAG Pharmaceuticals, Inc. | 2019-09-18 |
| A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) (NCT03619850) | AMAG Pharmaceuticals, Inc. | 2018-08-13 |
Track AMAG Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.